The traditional Bioresearch annual event presenting the latest Temporomandibular Dysfunction news in the dental care sector took place from 14th to 16th July at the “La Marquette” University Campus in Milwaukee, Wisconsin. The conference, now in its 50th edition, was attended by 150 dentists, and saw Lucio Zaghetto, the ASALaser Scientific and Educational Director, constitute the reference point for the laser session of the B2B meetings. A great deal of space was dedicated to MLS® Laser Therapy, whose devices have been present in the USA and Canada for quite some time, thanks to Bioresearch Assoc. Inc., the ASAlaser partner in the dental care sector, and the participants’ enthusiasm was also confirmed through the direct testimony of well-known specialists in the dental sector.
First of all, the intervention by Dr David E. Shirazi, DDS of the TMJ and Sleep Therapy Centre of Conejo Valley, described some of his experiences when using MLS® to control pain in dental care; then it was the turn of Dr Steven Olmos, the T&S Therapy Centre International Founder & CEO and International Educator, whose speech “TMD and Sleep Connections” related his personal daily experiences in treating pain and temporomandibular dysfunctions with MLS® Laser Therapy, and in fact the devices are in all his centres and MLS® is a routine treatment for all his patients.
The closure was just as engaging with the report entitled “TMJ to Restorative Transitions” given by Dr Michael A. Smith, DMD, who illustrated the advantages of using MLS® when treating “Cranio Facial dysfunction pain” and “restorative practice” pathologies.
Dr Shirazi’s words expressing his appreciation for our therapy were very significant “I could not be without my laser. I have two clinics and three MLS® laser devices which I regularly use to treat a broad range of pathologies (for example craniofacial pain or neck pain) and this is very important in my work. Normally when one buys a laser, this has been designed to solve one or two problems. MLS® however, allows multiple uses!"
“I am particularly happy with the outcome of the event -stated Lucio Zaghetto- once again the testimony of prestigious dentists has corroborated the efficiency of our MLS® Laser Therapy overseas. It was also a great pleasure to meet our clients, many of whom have equipped their centres with more than one device over time, such is their significant interest in our therapies”.
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.